ReviewSkeletal radiology2026
Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesions.
Review in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soft tissue-RADS scoring system for musculoskeletal (MSK) tumor and tumor-like lesions is recently published. The system includes diagnostic MRI flowcharts and algorithms for lipomatous masses, cyst-like or high-water content masses, and indeterminate-solid appearing masses with consistent and standardized management recommendations. MSK radiology and cancer imaging training commonly provides the essential skills needed to render appropriate prospective diagnosis for many non-neoplastic tumor-like lesions and various commonly encountered sarcomas. Such trained readers may benefit from additional advanced algorithms to accurately identify and categorize different benign tumors and sarcomas and correctly input them in the soft tissue-RADS scoring system. These algorithms are built from a comprehensive literature search to establish an evidence-based composite and are supported by the expert opinions of the multidisciplinary ACR-soft tissue-RADS team. In this article we provide (1) a literature review of multimodality imaging, immunopathology, and clinical findings of soft tissue tumors and tumor-like lesions, presented in 7 tables (condensed from the 12 tables published in the WHO classification of soft tissue tumors) with respective table summaries; (2) a suggested modality-based lexicon; and (3) advanced diagnostic algorithms for trained readers based on published evidence and expert opinion that feed into the soft tissue-RADS scoring system (categories 1-6). The purpose of this work is to provide comprehensive guidance on soft tissue-RADS scoring to help streamline care for soft tissue tumors and tumor-like lesions and optimize patient outcomes.
Indexed as
Identifiers
41862709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.